Rheumatoid arthritis

1. Semin Arthritis Rheum3 Jun 2026

   Risk of disease flare and clinical reversibility following discontinuation versus dose reduction of biological DMARDs in Rheumatoid arthritis: A systematic review and meta-analysis

   Meta-analysis

2. Arthritis Res Ther2 Jun 2026

   Cytokine-induced PD-L1 and PD-L2 expression is preserved but reverse signalling is altered in rheumatoid arthritis fibroblast-like synoviocytes

   Mechanistic study

3. Rheumatology (Oxford)2 Jun 2026

   Detecting inflammatory arthritis in hand smartphone photographs: development and validation of a computer vision model in clinical settings

   Diagnostic or prognostic study

4. Arthritis Care Res (Hoboken)2 Jun 2026

   Treatment Sequencing and Line of Therapy for Biologics and JAK Inhibitors in Patients With Rheumatoid Arthritis: Implications for Design and Uptake of New Drugs and Predictive Biomarker Diagnostics

   Cohort study

5. Arthritis Rheumatol1 Jun 2026

   Autoreactivity Versus Autoimmunity: Characteristics of Autoantigen‐Specific CD4 T Cells in Rheumatoid Arthritis and Health

   Mechanistic study

6. Ann Rheum Dis30 May 2026

   Enhanced lipolysis in synovial fibroblasts mark early pathogenic changes in RA-risk individuals

   Mechanistic study

7. Lancet Rheumatol28 May 2026

   The role of health literacy in clinical, treatment, and work-related outcomes in people with inflammatory arthritis in England: a cross-sectional study

   Cross-sectional study

8. RMD Open28 May 2026

   Induction of Cure in Early Arthritis (I CEA): results of a randomised clinical trial to compare three treatment strategies in recent onset undifferentiated arthritis

   Randomized controlled trial

9. Arthritis Res Ther28 May 2026

   Elevated ST2+ Tregs in RA-ILD: correlation with pulmonary fibrosis and the IL-33/ST2/AREG axis

   Mechanistic study

10. Ann Rheum Dis27 May 2026

    Progression from symptom onset to rheumatoid arthritis: is the trajectory similar in anticitrullinated protein antibody-positive and -negative disease? A comparative longitudinal study

    Cohort study

11. Joint Bone Spine26 May 2026

    Real-world comparison of herpes zoster risk among five Janus kinase inhibitors in rheumatoid arthritis: The ANSWER cohort study

    Cohort study

12. Rheumatology (Oxford)22 May 2026

    One-month delay in MTX initiation on RA outcomes: 1-year ancillary analysis of the VACIMRA trial

    Randomized controlled trial

13. RMD Open20 May 2026

    PD1 + TIGIT + CD4 + T cells predict response to anti-TNF in rheumatoid arthritis and spondyloarthritis

    Cohort study

14. Arthritis Res Ther19 May 2026

    Lipid metabolism dysregulation in rheumatoid arthritis: from multi-omics discovery to adjunctive therapy with conjugated linoleic acid

    Mechanistic study

15. RMD Open18 May 2026

    Validation of screening criteria for interstitial lung disease in rheumatoid arthritis in routine clinical practice: the VAR-EPIDSER study

    Diagnostic or prognostic study

16. Clin Exp Rheumatol16 May 2026

    Evaluation of combined anti-anaemia and DMARD therapy for rheumatoid arthritis-related anaemia: a retrospective cohort study

    Cohort study

17. Semin Arthritis Rheum16 May 2026

    Gender influence on ultrasound-assessed therapeutic response in rheumatoid arthritis: Insights from the GENder on UltraSound (GENUS) study

    Cohort study

18. Ann Rheum Dis13 May 2026

    Anti-PAD4 antibodies link autoimmunity to PAD4 with CTL-associated rheumatoid arthritis

    Mechanistic study

19. RMD Open12 May 2026

    Real-world effectiveness, safety and patient-reported outcomes of sarilumab in patients with rheumatoid arthritis: a 52-week, prospective, open-label, non-interventional, observational, nationwide, large-cohort study in Japan (PROFILE-J)

    Cohort study

20. Arthritis Care Res (Hoboken)12 May 2026

    Real‐World Trends in Prenatal Antirheumatic Drug Utilization in Ontario, Canada: A Cross‐Sectional Time‐Series Analysis

    Cross-sectional study

21. Arthritis Care Res (Hoboken)11 May 2026

    Rheumatoid Arthritis and Coronary Artery Calcium Progression: A Case Cohort Analysis From ELSA ‐Brasil

    Cohort study

22. Semin Arthritis Rheum8 May 2026

    Hospitalization risk in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis: A matched cohort study

    Cohort study

23. Rheumatology (Oxford)8 May 2026

    Circulatory microRNA signature distinguishing rheumatoid arthritis and psoriatic arthritis

    Cross-sectional study

24. RMD Open7 May 2026

    Changes in bone mineral density and fractures during 2 years of low-dose glucocorticoid treatment for rheumatoid arthritis: a systematic literature review and individual participant data meta-analysis

    Meta-analysis

25. Scand J Rheumatol7 May 2026

    Oral colonization of Pneumocystis jirovecii in patients with rheumatoid arthritis and respiratory symptoms: a substudy of the AURORA cohort

    Secondary analysis

26. Arthritis Rheumatol7 May 2026

    Machine Learning to Predict Remission Between 6 and 24 Months in Rheumatoid Arthritis: Insights From JAK, an International Registry Collaboration

    Diagnostic or prognostic study

27. Arthritis Res Ther6 May 2026

    Peripheral blood transcriptomic analysis of patients with rheumatoid arthritis associated interstitial lung disease reveals: distinct molecular signature with evidence of humoral and myeloid immunity

    Mechanistic study

28. Arthritis Care Res (Hoboken)5 May 2026

    Associations of Rheumatoid Arthritis Disease Activity With Frailty Over Five Years of Follow‐up

    Cohort study

29. RMD Open4 May 2026

    Prognostic impact of rheumatoid arthritis on respiratory-related mortality in non-tuberculous mycobacterial pulmonary disease

    Cohort study

30. Arthritis Care Res (Hoboken)4 May 2026

    The Painful Truth: The Relationship Between Nonarticular Pain and Patient Global Assessment Before and After Initiating a New Disease‐Modifying Antirheumatic Drug for Active Rheumatoid Arthritis

    Cohort study

31. Arthritis Rheumatol3 May 2026

    Lung Ultrasound for the Detection of Radiologic Progression of Interstitial Lung Abnormalities in Patients With Rheumatoid Arthritis

    Cohort study

32. Lancet Rheumatol1 May 2026

    Efficacy and safety of branebrutinib (BMS-986195), an irreversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2a, randomised, double-blind, placebo-controlled study

    Randomized controlled trial

33. J Rheumatol1 May 2026

    Deep Learning–Based Comparison of Knee Minimum Joint Space Width in Patients With Rheumatoid Arthritis and Osteoarthritis Before Total Knee Arthroplasty

    Cohort study

34. Ann Rheum Dis29 Apr 2026

    Dual dynamics of persistence and recruitment characterise the ACPA-expressing B cell response in rheumatoid arthritis

    Mechanistic study

35. RMD Open28 Apr 2026

    Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort

    Cohort study

36. RMD Open28 Apr 2026

    Cognitive impairment risk in patients with rheumatoid arthritis: a population-based cohort study

    Cohort study

37. Osteoporos Int28 Apr 2026

    Risk of fracture among patients with rheumatoid arthritis according to serological status: a population-based retrospective cohort study

    Cohort study

38. Ann Rheum Dis28 Apr 2026

    Reduced versus standard dosing of Janus kinase inhibitors in rheumatoid arthritis: a propensity score–matched real-world study accounting for poor prognostic factors

    Cohort study

39. Rheumatology (Oxford)28 Apr 2026

    Outcomes with transcatheter aortic valve replacement for aortic stenosis in rheumatoid arthritis: an observational study

    Cohort study

40. Rheumatology (Oxford)25 Apr 2026

    Pericoronary adipose tissue as a biomarker of coronary atherosclerosis and cardiovascular risk in rheumatoid arthritis

    Cohort study

All 1,564 Briefs in ExploreShowing Briefs 121–160 of 1,564, newest first